NCT00647634View on ClinicalTrials.gov

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Healthy
Interventions
DRUG

Alprazolam Extended-Release Tablets 3 mg

3mg, single dose fasting

DRUG

Xanax XR® Tablets (3 mg

3mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY